FDA Approves First mRNA Flu Vaccine After Initial Rejection
Science
✓ Neutralized●●●
1h ago

FDA Approves First mRNA Flu Vaccine After Initial Rejection

AI-synthesized · Bias removed · Facts only

The Food and Drug Administration has approved the first messenger RNA (mRNA) vaccine for seasonal flu, made by Moderna, for use in this year’s upcoming flu season. The approval comes after the FDA initially refused to review the request for the shot earlier this year.

The Washington Times reports that the FDA reversed its initial rejection of the vaccine. Live Science similarly notes the agency's prior refusal to review the approval request. No reason was given in the sources for the initial rejection or subsequent reversal. The availability of the shot for this year’s upcoming flu season has been confirmed.

Was this useful?

How we processed this story

  • ✓ Neutralized — Loaded language, emotional intensifiers, and editorial framing were stripped from the original coverage. Direct quotes are preserved verbatim. The change log is available on request.
  • ● Coverage — Three dots show whether left, center, and right outlets in our pool covered this story. Filled means yes, hollow means no. One-sided coverage is shown honestly — we don't hide it, and we don't penalize it.
  • ⚠ Wire — Flagged when "multiple" outlets are reprinting the same wire-service copy. Several reprints of one AP story are not three independent perspectives.

We don't rate truth. We strip the spin and show you which perspectives covered the story. You decide.

Read the original coverage

◀ Left Time Mag Read original ↗ ● Center Live Science Read original ↗ Right ▶ Washington Times Read original ↗

💬 Comments

📜 Comment Policy